It will also be prudent to consider the effect of symptomatic therapies on activity imbalance, given that activity gradients reflect neurotransmitter receptor distributions 29,71,30 and may be modulated by acetylcholinesterase inhibitors or selective serotonin reuptake inhibitors commonly used in dementia treatment. The gene discussed is ACHE; the disease is dementia.